Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89761035 | 8976103 | 5 | F | 20121102 | 20160824 | 20121220 | 20160901 | EXP | US-PFIZER INC-2012281679 | PFIZER | 61.00 | YR | F | Y | 84.40000 | KG | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89761035 | 8976103 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK UNK, 3X/DAY | 18989 | TABLET | TID | ||||||||
| 89761035 | 8976103 | 2 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 1000 MG, 2X/DAY | 132000 | MG | Y | 7073 | 1000 | MG | TABLET | BID | |||
| 89761035 | 8976103 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
| 89761035 | 8976103 | 4 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 | |||||||||||
| 89761035 | 8976103 | 5 | C | LOSARTAN. | LOSARTAN | 1 | UNK | 0 | |||||||||||
| 89761035 | 8976103 | 6 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | UNK | 0 | |||||||||||
| 89761035 | 8976103 | 7 | C | KRILL OIL OMEGA 3 | 2 | UNK | 0 | ||||||||||||
| 89761035 | 8976103 | 8 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 89761035 | 8976103 | 9 | C | CITRACAL + D | CALCIUM CITRATEVITAMIN D | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 89761035 | 8976103 | 1 | Osteoarthritis |
| 89761035 | 8976103 | 3 | Prophylaxis |
| 89761035 | 8976103 | 4 | Hypertension |
| 89761035 | 8976103 | 5 | Hypertension |
| 89761035 | 8976103 | 6 | Osteopenia |
| 89761035 | 8976103 | 7 | Prophylaxis |
| 89761035 | 8976103 | 8 | Osteoarthritis |
| 89761035 | 8976103 | 9 | Mineral supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 89761035 | 8976103 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 89761035 | 8976103 | Chest pain | |
| 89761035 | 8976103 | Dyspnoea | |
| 89761035 | 8976103 | Hypoxia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 89761035 | 8976103 | 1 | 20110517 | 20131205 | 0 | |
| 89761035 | 8976103 | 2 | 20120901 | 20121109 | 0 | |
| 89761035 | 8976103 | 3 | 20110620 | 0 | ||
| 89761035 | 8976103 | 4 | 20120413 | 0 | ||
| 89761035 | 8976103 | 5 | 20120715 | 0 | ||
| 89761035 | 8976103 | 6 | 20120801 | 0 | ||
| 89761035 | 8976103 | 7 | 20120901 | 0 | ||
| 89761035 | 8976103 | 8 | 20110801 | 0 | ||
| 89761035 | 8976103 | 9 | 20120801 | 0 |